subscribe: Posts | Comments

One third of patients stop breast cancer drugs due to side-effects

0 comments

Summary of story from BBCNews, December 9, 2011

A third of breast cancer patients stop their medication because of severe side-effects, a US study suggests.

Of 686 women surveyed by Northwestern University, 36 percent stopped taking aromatase inhibitors (see WVoN story) because of joint pain, hot flushes, weight gain and nausea.

The study, presented at the Annual San Antonio Breast Cancer Symposium, questioned women before treatment and three, six, 12 and 24 months into treatment.

The number reporting side-effects increased with the length of treatment.

Ten percent of women stopped the drug – used to treat oestrogen-sensitive breast cancer – within two years. A further 26 percent stopped within four years.

Researchers said there was a gap between what women told their doctors about side-effects and what they actually experienced.

The UK’s senior policy officer at Breakthrough Breast Cancer, Dr Susie Jennings, said: “We are aware some patients in the UK do stop treatments early and the reasons behind this need further investigation.

“It is important there is a continued discussion throughout treatment between patient and doctor.”

Dr Lynne Wagner, who led the study, said it was a wake-up call for clinicians who underestimated the side-effects.

“Patients don’t want to be complainers and don’t want their doctor to discontinue treatment,” she said. “We need to be better at managing the symptoms of our patients to improve their quality of life.”

Leave a Reply

Your email address will not be published. Required fields are marked *